|
|
|
Insider
Information: |
Wheeler Kurt |
Relationship: |
10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
8,638,466 |
|
Indirect Shares
|
50,230,112 |
|
|
Direct
Value |
$53,673,527 |
|
|
Indirect Value
|
$221,892,016 |
|
|
Total
Shares |
58,868,578 |
|
|
Total
Value |
$275,565,543 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
6
|
Stock
price went up :
|
1
|
6
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
1.0
|
6.0
|
Percentage
Gain/Loss : |
12.5%
|
44.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Rigel Pharmaceuticals Inc |
RIGL |
10% Owner |
2003-06-26 |
3,612,947 |
2004-09-13 |
475,026 |
Premium* |
|
Cyclacel Pharmaceuticals Inc |
CYCC |
10% Owner |
|
0 |
2004-03-16 |
87,899 |
Premium* |
|
Hemosense Inc |
HEM |
Director, 10% Owner |
2005-07-01 |
0 |
2007-11-06 |
0 |
Premium* |
|
American Cryostem Corporation |
CRYO |
Director, 10% Owner |
2005-07-13 |
0 |
2008-05-28 |
0 |
Premium* |
|
Somaxon Pharmaceuticals, Inc. |
SOMX |
Director, 10% Owner |
2009-12-31 |
57,377 |
2009-12-31 |
4,632,562 |
Premium* |
|
Poniard Pharmaceuticals |
PARD |
10% Owner |
|
0 |
2009-11-09 |
6,363,249 |
Premium* |
|
Affymax Inc |
AFFY |
10% Owner |
|
0 |
2006-12-20 |
1,600,469 |
Premium* |
|
Helicos Biosciences Corp |
HLCSQ |
10% Owner |
2007-05-30 |
0 |
2007-05-30 |
2,987,769 |
Premium* |
|
Ithaka Acquisition Corp |
ITHKU |
Director, 10% Owner |
|
0 |
2007-06-21 |
2,672,568 |
Premium* |
|
Aryx Therapeutics Inc |
ARYX |
10% Owner |
2007-11-13 |
0 |
2008-11-14 |
5,364,572 |
Premium* |
|
Epirus Biopharmaceuticals Inc |
EPRS |
10% Owner |
|
0 |
2011-10-27 |
11,133,961 |
Premium* |
|
Aveo Pharmaceuticals Inc |
AVEO |
Former 10% Stockholder |
2010-03-17 |
0 |
2010-03-17 |
2,208,961 |
Premium* |
|
Zogenix, Inc. |
ZGNX |
Director, 10% Owner |
2010-11-29 |
0 |
2010-11-29 |
5,982,439 |
Premium* |
|
Humanigen Inc |
HGEN |
10% Owner |
2013-02-05 |
0 |
2013-02-05 |
2,632,928 |
Premium* |
|
Aerie Pharmaceuticals Inc |
AERI |
10% Owner |
2015-01-28 |
0 |
2013-10-25 |
0 |
Premium* |
|
Oxford Immunotec Global Plc |
OXFD |
10% Owner |
2015-06-16 |
2,237,377 |
2013-11-22 |
0 |
Premium* |
|
Radius Health Inc. |
RDUS |
Former 10% stockholder |
2014-06-06 |
0 |
2016-09-27 |
2,459,804 |
Premium* |
|
Iveric Bio Inc |
ISEE |
10% Owner |
2015-05-26 |
0 |
2014-06-11 |
4,500 |
Premium* |
|
Sientra, Inc. |
SIEN |
10% Owner |
2014-10-28 |
2,730,765 |
|
0 |
Premium* |
|
Entasis Therapeutics Holdings Inc. |
ETTX |
10% Owner |
2018-09-28 |
0 |
2018-09-28 |
1,623,405 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
137 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CYCC |
Cyclacel Pharmaceuticals ... |
10% Owner |
|
2004-03-16 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
87,899 |
|
- |
|
EPRS |
Epirus Biopharmaceuticals... |
10% Owner |
|
2009-12-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
22,547,613 |
|
- |
|
EPRS |
Epirus Biopharmaceuticals... |
10% Owner |
|
2010-01-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(7,913,653) |
14,633,961 |
0 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
10% Owner |
|
2011-09-26 |
4 |
S |
$1.11 |
$233,100 |
I/I |
(210,000) |
14,423,961 |
0 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
10% Owner |
|
2011-09-27 |
4 |
S |
$1.09 |
$218,000 |
I/I |
(200,000) |
14,223,961 |
0 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
10% Owner |
|
2011-09-28 |
4 |
S |
$1.02 |
$102,000 |
I/I |
(100,000) |
14,123,961 |
0 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
10% Owner |
|
2011-09-29 |
4 |
S |
$1.02 |
$54,876 |
I/I |
(53,800) |
14,070,161 |
0 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
10% Owner |
|
2011-09-30 |
4 |
S |
$1.02 |
$23,774 |
I/I |
(23,308) |
14,046,853 |
0 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
10% Owner |
|
2011-10-05 |
4 |
S |
$1.02 |
$33,786 |
I/I |
(33,124) |
14,013,729 |
0 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
10% Owner |
|
2011-10-06 |
4 |
S |
$1.02 |
$173,400 |
I/I |
(170,000) |
13,843,729 |
0 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
10% Owner |
|
2011-10-07 |
4 |
S |
$1.03 |
$283,456 |
I/I |
(275,200) |
13,568,529 |
0 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
10% Owner |
|
2011-10-10 |
4 |
S |
$1.04 |
$239,200 |
I/I |
(230,000) |
13,338,529 |
0 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
10% Owner |
|
2011-10-11 |
4 |
S |
$1.02 |
$210,630 |
I/I |
(206,500) |
13,132,029 |
0 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
10% Owner |
|
2011-10-12 |
4 |
S |
$102.00 |
$13,443,600 |
I/I |
(131,800) |
13,000,229 |
0 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
10% Owner |
|
2011-10-13 |
4 |
S |
$1.02 |
$5,100 |
I/I |
(5,000) |
12,995,229 |
0 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
10% Owner |
|
2011-10-14 |
4 |
S |
$1.02 |
$40,494 |
I/I |
(39,700) |
12,955,529 |
0 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
10% Owner |
|
2011-10-17 |
4 |
S |
$1.02 |
$20,037 |
I/I |
(19,644) |
12,935,885 |
0 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
10% Owner |
|
2011-10-19 |
4 |
S |
$1.02 |
$35,513 |
I/I |
(34,817) |
12,901,068 |
0 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
10% Owner |
|
2011-10-20 |
4 |
S |
$1.03 |
$437,750 |
I/I |
(425,000) |
12,476,068 |
0 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
10% Owner |
|
2011-10-21 |
4 |
S |
$1.02 |
$71,502 |
I/I |
(70,100) |
12,405,968 |
0 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
10% Owner |
|
2011-10-24 |
4 |
S |
$1.03 |
$259,560 |
I/I |
(252,000) |
12,153,968 |
0 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
10% Owner |
|
2011-10-25 |
4 |
S |
$1.02 |
$207,264 |
I/I |
(203,200) |
11,950,768 |
0 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
10% Owner |
|
2011-10-26 |
4 |
S |
$1.02 |
$79,560 |
I/I |
(78,000) |
11,872,768 |
0 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
10% Owner |
|
2011-10-27 |
4 |
S |
$1.03 |
$760,971 |
I/I |
(738,807) |
11,133,961 |
0 |
- |
|
ETTX |
Entasis Therapeutics Hold... |
10% Owner |
|
2018-09-28 |
4 |
B |
$15.00 |
$6,800,925 |
I/I |
453,395 |
1,623,405 |
1.5 |
- |
|
137 Records found
|
|
Page 2 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|